After 1,451 days, the stage was set for Mikaela Shiffrin to end her Olympic hex in style Tuesday with a little help from a ...

Authorities have confirmed that there has been no loss of life or injury reported so far. A series of landmine blasts occurred along the Line of Control (LoC) in Jammu and Kashmir's Poonch district ...

It appears a recent line said on AEW Dynamite wasn’t approved ahead of time. This line resulted in multiple people in the company not being happy about it. Last month, AEW Dynamite took place overseas ...

When an Immigration and Customs Enforcement agent shot and killed 37-year-old Renee Nicole Good in Minneapolis on Wednesday, it was not the first time that federal officers have killed civilians since ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient outcomes and possible cures. In this episode, experts discuss how bispecific ...

INDIANAPOLIS — The Indiana Department of Transportation's Clear Path project is nearing the finish line. It is about 80% complete, and almost all new bridges are finished and open. INDOT said ...

The Iowa State Cyclones lost a ton of players to the transfer portal when it was announced that Matt Campbell was taking the head coach position with the Penn State Nittany Lions, being replaced by ...

Note: MD5 and CRC32 are included for compatibility and fast checksums only — do not use them for cryptographic security. You can pass multiple files or directories; each is processed in turn. A ...

The Pittsburgh Steelers are making a series of moves to fortify their offensive line after multiple injuries there. Broderick Jones and Calvin Anderson are both on injured reserve while Andrus Peat is ...

A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that could put some pressure on CAR T-cell therapies, including the company’s own ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...